| CAS: | 294646-77-8 | ||||
| 分子式: | C24H29N7O | ||||
| 分子量: | 431.5334 | ||||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||
| R918727 | MACKLIN | (R)-2-((9-异丙基-6-((4-(吡啶-2-基)苄基)氨基)-9H-嘌呤-2-基)氨基)丁醇 | 99% | 116元/1mg; 514元/10mg; | 咨询 | ||||||||||||||||||||||||||||||||||||||
储存:2-8°C,密闭,干燥 状态:灰白色粉末 | |||||||||||||||||||||||||||||||||||||||||||
| C3249 | Sigma-Aldrich | CR8 | ≥95% (HPLC) | 3076.41元/5 MG; 12317.2元/25 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||
产品说明 包装 5, 25 mg in glass bottle 生化/生理作用 CR8 is a potent and selective inhibitor of cyclin dependent kinase (CDK1, 2, 5, 7, and 9). CR8 is a more potent pyridyl analogue of roscovitine (Cat. No. R7772). In comparison to roscovirtine, the compound gains in potency toward CK1, which is involved in amyloid-β formation. The R-CR8 enantiomer is slightly more potent than S. CR8 is around 30 times more potent at cellular assay then roscovitine. Acts as a molecular glue to induce cyclin K degradation. 特点和优势 This compound is featured on the CDKs page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||